Scholarlink

<p>Hypertensive disorders in pregnancy are common and carry significant maternal and fetal risks. Robust evidence from the CHAP- and CHIP-studies support clear management strategies including validated home or office blood pressure measurements, organ function assessment and sFlt-1/PIGF quotient for preeclampsia risk stratification. Treatment thresholds balance maternal protection and fetal growth, with methyldopa, nifedipine and metoprolol as primary options. Postpartum follow-up is essential, as affected women have lifelong elevated cardiovascular risk.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bluthochdruck-Management in der Schwangerschaft und Stillzeit

  • 期刊论文

  • 发表日期：

    2025年11月7日

查看全文
  • Milen Babic

摘要

Hypertensive disorders in pregnancy are common and carry significant maternal and fetal risks. Robust evidence from the CHAP- and CHIP-studies support clear management strategies including validated home or office blood pressure measurements, organ function assessment and sFlt-1/PIGF quotient for preeclampsia risk stratification. Treatment thresholds balance maternal protection and fetal growth, with methyldopa, nifedipine and metoprolol as primary options. Postpartum follow-up is essential, as affected women have lifelong elevated cardiovascular risk.